Jean-Pierre Gotteland
Nessuna posizione attualmente
Profilo
Jean-Pierre Gotteland worked as a Director of Research Project at Serono SA from 1998 to 2007.
He then worked as a Research Scientist at Pierre Fabre Médicament SAS.
From 2007 to 2015, he worked at PregLem SA as Vice President of Non-Clinical Development.
He then worked at ObsEva SA from 2015 to 2022 as Chief Scientific Officer and Head of R&D.
Dr. Gotteland received a doctorate degree from Université Claude Bernard Lyon 1 in 1989 and an undergraduate degree from École Supérieure de Physique et de Chimie de Paris.
Precedenti posizioni note di Jean-Pierre Gotteland
| Società | Posizione | Fine |
|---|---|---|
| OBSEVA SA | Chief Tech/Sci/R&D Officer | 30/09/2022 |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | 01/08/2015 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | 01/01/2007 |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Chief Tech/Sci/R&D Officer | 31/12/1889 |
Formazione di Jean-Pierre Gotteland
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| École Supérieure de Physique et de Chimie de Paris | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OBSEVA SA | Health Technology |
| Aziende private | 3 |
|---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Jean-Pierre Gotteland
